tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
RAPP
Rapport Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see RAPP full AI Analyst Report?

Rapport Therapeutics, Inc. (RAPP) Financial Statements

143 Followers

Rapport Therapeutics, Inc. Financial Overview

Rapport Therapeutics, Inc.'s market cap is currently $1.69B. The company's EPS TTM is $-0.72; its P/E ratio is -10.55; Rapport Therapeutics, Inc. is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.02M$ -839.00K$ -112.00K$ -15.00K
Operating Income$ -125.10M$ -83.06M$ -36.18M$ -10.37M
EBITDA$ -124.08M$ -77.47M$ -34.66M$ -10.35M
Net Income$ -111.48M$ -78.31M$ -34.79M$ -10.65M
Balance Sheet
Cash & Short-Term Investments$ 490.54M$ 305.28M$ 147.48M$ 31.16M
Total Assets$ 512.43M$ 314.93M$ 155.42M$ 31.60M
Total Debt$ 11.48M$ 1.48M$ 2.15M$ 10.44M
Net Debt$ -41.16M$ -55.33M$ -68.02M$ -20.72M
Total Liabilities$ 27.78M$ 9.51M$ 181.06M$ 12.10M
Stockholders' Equity$ 484.65M$ 305.43M$ -25.63M$ 19.50M
Cash Flow
Free Cash Flow$ -88.09M$ -67.23M$ -28.82M$ -3.53M
Operating Cash Flow$ -87.47M$ -64.83M$ -27.18M$ -3.24M
Investing Cash Flow$ -187.47M$ -170.14M$ -78.86M$ -5.28M
Financing Cash Flow$ 270.79M$ 221.63M$ 145.14M$ 39.69M
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Rapport Therapeutics, Inc. Debt to Assets

Balance Sheet >

Rapport Therapeutics, Inc. Cash Flow

Cash Flow >

Rapport Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >